Many of these findings were determined using the proprietary breath testing instruments and state-of-the-art collection kits developed and distributed by Gemelli Biotech using the only three-gas, mail ...
VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the "Company or Cannabix") is pleased to announce that the ...
A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians. A breath test could be useful in caring for chronic pain patients as well as for checking for illegal ...
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two ...
The US Food and Drug Administration recently authorized emergency use of the Inspectir Breathalyzer — a diagnostic test that uses exhalations, rather than nasal swab samples, to detect the presence of ...
Cannabix Technologies (CSE:BLO)(USOTC:BLOZF)(Frankfurt: 8CT)has announced a potentially transformative advancement in the field of breath-based drug testing, successfully detecting methamphetamine and ...
LOS ANGELES & RALEIGH, N.C.--(BUSINESS WIRE)--Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart™ that provides a more complete fermented gas ...